《2018年农业改进法案》（即2018年农业法案）通过将大麻及其衍生物从《管制物质法案》中定义的大麻范畴中移除，并为大麻种植提供详细框架，从而实现了大麻合法化。该法案赋予美国农业部（USDA）对联邦层面大麻种植的监管权。 各州可选择向美国农业部提交计划，从而保留对其辖区内种植作物的主要监管权。
联邦与州层面的相互作用已促使各州出台多项立法和监管改革。事实上，多数州已提出（并通过）法案，授权在本州境内进行工业大麻的商业化生产。此外，虽数量较少但呈增长趋势的州也开始对工业大麻衍生产品的销售实施监管。
In light of the rapidly evolving legislative changes, we are also presenting a 50-state series analyzing how each jurisdiction treats hemp-derived cannabidiol (Hemp CBD). Today we turn to North Dakota.
In 2019, North Dakota legalized the cultivation of hemp under the 2014 Farm Bill. However, the new law (HB 1349) does not address the regulation of Hemp-CBD products.
According to guidelines released by the Attorney General (AG), the state seems to defer to FDA guidance when regulating Hemp-CBD products. In addition, even following the enactment of HB 1349, which excludes the term “hemp” from marijuana, law enforcement remained hostile to Hemp-CBD making the sale of these products in the state risky.
Given that the state has decided not to submit a plan under the 2018 Farm Bill and instead continues operating under the 2014 Farm Bill until it expires on October 30, 2020, it seems unlikely that North Dakota will change its position on the sale of these products. So for the time being, CBD companies should refrain from selling their products in this not-so-hemp-friendly state.
本系列往期报道请参阅以下链接：
